- Home
- SUPN vs MANU Comparison
SUPN vs MANU Comparison
Compare SUPN & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- MANU
- Stock Information
- Founded
- SUPN 2005
- MANU 1878
- Country
- SUPN United States
- MANU United Kingdom
- Employees
- SUPN N/A
- MANU N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- MANU Services-Misc. Amusement & Recreation
- Sector
- SUPN Health Care
- MANU Consumer Discretionary
- Exchange
- SUPN Nasdaq
- MANU Nasdaq
- Market Cap
- SUPN 2.6B
- MANU 3.0B
- IPO Year
- SUPN 2012
- MANU 2012
- Fundamental
- Price
- SUPN $44.80
- MANU $15.39
- Analyst Decision
- SUPN Buy
- MANU Strong Buy
- Analyst Count
- SUPN 2
- MANU 1
- Target Price
- SUPN $43.00
- MANU $23.00
- AVG Volume (30 Days)
- SUPN 654.2K
- MANU 359.5K
- Earning Date
- SUPN 11-03-2025
- MANU 09-17-2025
- Dividend Yield
- SUPN N/A
- MANU N/A
- EPS Growth
- SUPN 1411.53
- MANU N/A
- EPS
- SUPN 1.14
- MANU N/A
- Revenue
- SUPN $665,125,000.00
- MANU $913,157,967.00
- Revenue This Year
- SUPN $4.84
- MANU $2.95
- Revenue Next Year
- SUPN $17.69
- MANU $2.10
- P/E Ratio
- SUPN $38.93
- MANU N/A
- Revenue Growth
- SUPN 5.55
- MANU 0.72
- 52 Week Low
- SUPN $29.16
- MANU $12.05
- 52 Week High
- SUPN $46.79
- MANU $19.65
- Technical
- Relative Strength Index (RSI)
- SUPN 58.16
- MANU 35.78
- Support Level
- SUPN $43.44
- MANU $15.52
- Resistance Level
- SUPN $46.72
- MANU $16.45
- Average True Range (ATR)
- SUPN 1.08
- MANU 0.66
- MACD
- SUPN -0.48
- MANU -0.05
- Stochastic Oscillator
- SUPN 40.60
- MANU 24.34
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.